insulin biosimilar
Dec 15, 2021
Insights into some of the Biosimilar Drugs that are approved and launched in 2021
Since the first biosimilar drug was approved in 2006, the EU has led the way in biosimilar regulation. Over the last decade, the EU has authorized the most biosimilars globally, gathering significant expertise with their usage and safety. Over ten years of clinical experience has shown that biosimilars licensed by ...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
